ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 885 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 885; 2) Community: the network communities that were significantly associated with the response to NSC 885; 3) Molecule: the relationships between components within communities and NSC 885; 4) MDR: the compounds that were significantly associated with the NSC 885.

NSC Compound Enrichment Correlation
NSC 159631 Ergochrome AA (2,2')-5-.beta.,6-.alpha.,10-.beta.-5',6'-.alpha.,10'-.beta. 0.0187206825450448 0.25221423
NSC 180973 Tamoxifen citrate 0.0187206825450448 0.35103241
NSC 24030 p-Phenylenediamine (8CI), N-butyl-N'-phenyl- 0.0187206825450448 0.12470222
NSC 256927 CHIP 0.0187206825450448 0.11638709
NSC 309401 2H-Pyrrolo[3,2-f]quinazoline-2,4(3H)-diamine, 3-[(3-aminophenyl)methyl]-, dihydrochloride 0.0187206825450448 0.19703382
NSC 320877 Geldanamycin, 17-[(2-chloroethyl)amino]-17-demethoxy- 0.0187206825450448 0.33837841
NSC 46683 Null 0.0187206825450448 0.72625503
NSC 620687 Null 0.0187206825450448 0.18302232
NSC 623794 1,4-Benzodioxin-2-carboxamide, 6-(4-oxo-4-H-1- benzopyran-2-yl)-N-(3-pyridinylmethyl)- 0.0187206825450448 -0.24453948
NSC 626878 Cyclopentanone, 2-[(dimethylamino)methyl]-5-pentylidene-, hydrochloride 0.0187206825450448 0.19236937
Total:124  Current:62    [First] [Prev] [Next] [Last]